Výsledky vyhľadávania - "Forsman, Lina Davies"
-
1
A Rough Colony Morphology of Mycobacterium abscessus Is Associated With Cavitary Pulmonary Disease and Poor Clinical Outcome
ISSN: 0022-1899, 1537-6613, 1537-6613Vydavateľské údaje: United States Oxford University Press 28.03.2023Vydané v The Journal of infectious diseases (28.03.2023)“…Abstract Background The Mycobacterium abscessus complex (MABC) is a difficult to treat mycobacterium with two distinct morphologies: smooth and rough. As the…”
Získať plný text
Journal Article -
2
Understanding tuberculosis among people with tuberculosis through an educational film: a qualitative study
ISSN: 2044-6055, 2044-6055Vydavateľské údaje: England British Medical Journal Publishing Group 19.08.2025Vydané v BMJ open (19.08.2025)“…IntroductionTreatment of the two billion people with tuberculosis (TB) infection worldwide is crucial to prevent progression to TB disease and thereby prevent…”
Získať plný text
Journal Article -
3
New Oxazolidinones for Tuberculosis: Are Novel Treatments on the Horizon?
ISSN: 1999-4923, 1999-4923Vydavateľské údaje: Switzerland MDPI AG 17.06.2024Vydané v Pharmaceutics (17.06.2024)“…Multidrug-resistant tuberculosis (MDR-TB) is a global health concern. Standard treatment involves the use of linezolid, a repurposed oxazolidinone. It is…”
Získať plný text
Journal Article -
4
Additional drug resistance for Mycobacterium tuberculosis during turnaround time for drug-susceptibility testing in China: A multicenter observational cohort study
ISSN: 1201-9712, 1878-3511, 1878-3511Vydavateľské údaje: Canada Elsevier Ltd 01.07.2021Vydané v International journal of infectious diseases (01.07.2021)“…•One third developed extra drug resistance within turnaround time for DST results.•One fourth of MDR Mtb acquired PZA/EMB resistance within turnaround time for…”
Získať plný text
Journal Article -
5
Improved treatment outcome of multidrug-resistant tuberculosis with the use of a rapid molecular test to detect drug resistance in China
ISSN: 1201-9712, 1878-3511, 1878-3511Vydavateľské údaje: Canada Elsevier Ltd 01.07.2020Vydané v International journal of infectious diseases (01.07.2020)“…•Molecular drug susceptibility testing (DST) significantly reduced time to multidrug-resistant tuberculosis (MDR-TB) diagnosis.•Molecular DST contributed to a…”
Získať plný text
Journal Article -
6
Correlation of drug exposure and bacterial susceptibility with treatment response for Mycobacterium avium complex lung disease: protocol for a prospective observational cohort study
ISSN: 2044-6055, 2044-6055Vydavateľské údaje: London British Medical Journal Publishing Group 03.10.2023Vydané v BMJ open (03.10.2023)“…IntroductionThe burden of Mycobacterium avium complex (MAC) lung disease is increasing globally and treatment outcome is in general poor. Therapeutic drug…”
Získať plný text
Journal Article -
7
A modeling‐based proposal for safe and efficacious reintroduction of bedaquiline after dose interruption: A population pharmacokinetics study
ISSN: 2163-8306, 2163-8306Vydavateľské údaje: United States John Wiley & Sons, Inc 01.05.2022Vydané v CPT: pharmacometrics and systems pharmacology (01.05.2022)“…Bedaquiline (BDQ) is recommended for treatment of multidrug‐resistant tuberculosis (MDR‐TB) for the majority of patients. Given its long terminal half‐life and…”
Získať plný text
Journal Article -
8
In vitro activity of new combinations of β-lactam and β-lactamase inhibitors against the Mycobacterium tuberculosis complex
ISSN: 2165-0497, 2165-0497Vydavateľské údaje: 1752 N St., N.W., Washington, DC American Society for Microbiology 01.10.2023Vydané v Microbiology spectrum (01.10.2023)“…As meropenem-clavulanic acid is recommended for the treatment of drug-resistant tuberculosis, the repurposing of new carbapenem combinations may provide new…”
Získať plný text
Journal Article -
9
Safety and tolerability of clarithromycin in the treatment of multidrug-resistant tuberculosis
ISSN: 1399-3003, 1399-3003Vydavateľské údaje: England 01.03.2017Vydané v The European respiratory journal (01.03.2017)Zistit podrobnosti o prístupe
Journal Article -
10
The in vitro effect of new combinations of carbapenem-β-lactamase inhibitors for Mycobacterium abscessus
ISSN: 1098-6596, 1098-6596Vydavateľské údaje: 18.10.2023Vydané v Antimicrobial agents and chemotherapy (18.10.2023)“…As new treatment alternatives for Mycobacterium abscessus complex (MABC) are urgently needed, we determined the minimum inhibitory concentrations (MICs) for…”
Zistit podrobnosti o prístupe
Journal Article -
11
Plasma concentrations of second-line antituberculosis drugs in relation to minimum inhibitory concentrations in multidrug-resistant tuberculosis patients in China: a study protocol of a prospective observational cohort study
ISSN: 2044-6055, 2044-6055Vydavateľské údaje: England BMJ Publishing Group LTD 2018Vydané v BMJ open (2018)“…IntroductionIndividualised treatment through therapeutic drug monitoring (TDM) may improve tuberculosis (TB) treatment outcomes but is not routinely…”
Získať plný text
Journal Article -
12
Drug exposure and susceptibility of second-line drugs correlate with treatment response in patients with multidrug-resistant tuberculosis: a multicentre prospective cohort study in China
ISSN: 1399-3003, 1399-3003Vydavateľské údaje: England 01.03.2022Vydané v The European respiratory journal (01.03.2022)“…Understanding the impact of drug exposure and susceptibility on treatment response of multidrug-resistant tuberculosis (MDR-TB) will help to optimise…”
Zistit podrobnosti o prístupe
Journal Article -
13
Detection of Pyrazinamide Heteroresistance in Mycobacterium tuberculosis
ISSN: 1098-6596, 1098-6596Vydavateľské údaje: United States 17.08.2021Vydané v Antimicrobial agents and chemotherapy (17.08.2021)“…Heteroresistance is defined as the coexistence of both susceptible and resistant bacteria in a bacterial population. Previously published data show that it may…”
Zistit podrobnosti o prístupe
Journal Article -
14
Salivary Therapeutic Drug Monitoring of Antimicrobial Therapy: Feasible or Futile?
ISSN: 0312-5963, 1179-1926, 1179-1926Vydavateľské údaje: Cham Springer International Publishing 01.03.2024Vydané v Clinical pharmacokinetics (01.03.2024)“…Personalised drug dosing through therapeutic drug monitoring (TDM) is important to maximise efficacy and to minimise toxicity. Hurdles preventing broad…”
Získať plný text
Journal Article -
15
Increased risk of adverse drug reactions by higher linezolid dose per weight in multidrug-resistant tuberculosis
ISSN: 0924-8579, 1872-7913, 1872-7913Vydavateľské údaje: Netherlands Elsevier Ltd 01.10.2024Vydané v International journal of antimicrobial agents (01.10.2024)“…Linezolid treatment has a high risk of toxicity and adverse drug reactions (ADR) are frequent. Few studies have investigated risk factors of major ADRs…”
Získať plný text
Journal Article -
16
Population Pharmacokinetics and Dose Evaluation of Cycloserine among Patients with Multidrug-Resistant Tuberculosis under Standardized Treatment Regimens
ISSN: 1098-6596, 1098-6596Vydavateľské údaje: United States 17.05.2023Vydané v Antimicrobial agents and chemotherapy (17.05.2023)“…Although cycloserine is a recommended drug for the treatment of multidrug-resistant tuberculosis (MDR-TB) according to World Health Organization (WHO), few…”
Zistit podrobnosti o prístupe
Journal Article -
17
Development and validation of a simple LC-MS/MS method for simultaneous determination of moxifloxacin, levofloxacin, prothionamide, pyrazinamide and ethambutol in human plasma
ISSN: 1570-0232, 1873-376X, 1873-376XVydavateľské údaje: Netherlands Elsevier B.V 20.11.2020Vydané v Journal of chromatography. B, Analytical technologies in the biomedical and life sciences (20.11.2020)“…•Five antituberculosis drugs are simultaneously determined in plasma by LC-MS/MS.•Analytes are moxifloxacin, levofloxacin, prothionamide, pyrazinamide and…”
Získať plný text
Journal Article -
18
Drug exposure of first‐line anti‐tuberculosis drugs in China: A prospective pharmacological cohort study
ISSN: 0306-5251, 1365-2125, 1365-2125Vydavateľské údaje: England 01.03.2021Vydané v British journal of clinical pharmacology (01.03.2021)“…Aim Exploring the need for optimization of drug exposure to improve tuberculosis (TB) treatment outcome is of great importance. We aimed to describe drug…”
Získať plný text
Journal Article -
19
Genotypic Resistance of Pyrazinamide but Not Minimum Inhibitory Concentration Is Associated With Longer Time to Sputum Culture Conversion in Patients With Multidrug-resistant Tuberculosis
ISSN: 1537-6591, 1537-6591Vydavateľské údaje: 02.11.2021Vydané v Clinical infectious diseases (02.11.2021)“…Pyrazinamide (PZA) resistance in multidrug-resistant tuberculosis (MDR-TB) is common; yet, it is not clear how it affects interim and treatment outcomes…”
Zistit podrobnosti o prístupe
Journal Article -
20
Suboptimal moxifloxacin and levofloxacin drug exposure during treatment of patients with multidrug-resistant tuberculosis: results from a prospective study in China
ISSN: 1399-3003, 1399-3003Vydavateľské údaje: England 01.03.2021Vydané v The European respiratory journal (01.03.2021)Zistit podrobnosti o prístupe
Journal Article